Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Profit After Tax (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Profit After Tax came in at $5.5 billion in Q2 2026, little changed year-over-year from $5.5 billion in Q2 2025, and up 5.71% quarter-over-quarter from $5.2 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Profit After Tax (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Profit After Tax across 18 years of filings, most recently posting $5.5 billion for Q2 2026.

  • In Q2 2026, Profit After Tax changed 0.05% year-over-year to $5.5 billion; the TTM figure through Jun 2026 stood at $21.0 billion (down 7.17% YoY), while the FY2025 annual figure was $26.8 billion, up 90.56% from the prior year.
  • Profit After Tax came in at $5.5 billion for Q2 2026 at Johnson & Johnson, up from $5.2 billion in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $26.0 billion in Q4 2023 to a low of -$491.0 million in Q2 2023.
  • Average Profit After Tax over 5 years is $5.8 billion, with a median of $5.0 billion recorded in 2022.
  • Year-over-year, Profit After Tax sank 109.54% in 2023 and soared 762.93% in 2024.
  • Over 5 years, Profit After Tax stood at $4.5 billion in 2022, then retreated by 7.31% to $4.1 billion in 2023, then decreased by 16.97% to $3.4 billion in 2024, then jumped by 49.11% to $5.1 billion in 2025, then increased by 8.17% to $5.5 billion in 2026.
  • Per Business Quant data, the three most recent Profit After Tax figures were $5.5 billion in Q2 2026, $5.2 billion in Q1 2026, and $5.1 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 5.53 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 3.62 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 3.26 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -248.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 438.21 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -644.37 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 333.00 Mn
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 149.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 5.53 Bn
Mar 29, 2026 5.24 Bn
Dec 28, 2025 5.12 Bn
Sep 28, 2025 5.15 Bn
Jun 29, 2025 5.54 Bn
Mar 30, 2025 11.00 Bn
Dec 29, 2024 3.43 Bn
Sep 29, 2024 2.69 Bn
Jun 30, 2024 4.69 Bn
Mar 31, 2024 3.26 Bn
Dec 31, 2023 4.13 Bn
Oct 1, 2023 26.03 Bn
Jul 2, 2023 5.38 Bn
Apr 2, 2023 -491.00 Mn
Jan 1, 2023 3.52 Bn
Oct 2, 2022 4.46 Bn
Jul 3, 2022 4.81 Bn
Apr 3, 2022 5.15 Bn
Oct 3, 2021 3.67 Bn
Jul 4, 2021 6.28 Bn